If you already know you want a targeted formula, you can also browse the Healthy Aging Supplements collection
A new drug application was reportedly submitted in late 2025, putting it closest to potential approval
This medication is not suitable for people with glaucoma, hyperthyroidism, or a history of stroke, substance use disorder, or some types of psychiatric illness
Tirzepatide versus semaglutide In the direct head-to-head comparison, the 1-year risk of the primary endpoint including all-cause mortality was 1.3% (95% CI 1.2% to 1.5%) for tirzepatide and 1.3% (95% CI 1.2% to 1.5%) for semaglutide, resulting in a risk difference of 0.0% (95% CI 0.2% to 0.2%) and an HR of 1.06 (95% CI 0.95 to 1.18) (Fig
A meta-analysis has indeed highlighted that only about 5060% of patients with diabetes adhere to antidiabetic therapy [69], with a significant impact on quality of life and life expectancy
Clinical studies reveal that semaglutide use generally doesnt greatly alter thyroid hormones, though some research suggests potential benefits for individuals with both type 2 diabetes and hypothyroidism